Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Dec 6, 2024
BACKGROUND AND PURPOSE: Fast, high-quality deep learning (DL) prediction of patient-specific 3D dose distributions can enable instantaneous treatment planning (IP), in which the treating physician can evaluate the dose and approve the plan immediatel...
International journal of biological macromolecules
Dec 4, 2024
Although recent advancements have shed light on the crucial role of coordinated evolution among cell subpopulations in influencing disease progression, the full potential of these insights has not yet been fully harnessed in the clinical application ...
PURPOSE: To evaluate the effect of lower field strength on quantitative apparent-diffusion-coefficient (ADC) values, contrast of the T2-weighted MR images and the performance of an AI-based segmentation.
Journal of applied clinical medical physics
Dec 1, 2024
PURPOSE: This study aimed to investigate the dosimetric impact of deep-learning-based auto-contouring for clinical target volume (CTV) and organs at risk (OARs) delineation in prostate cancer radiotherapy planning. Additionally, we compared the geome...
Journal of applied clinical medical physics
Nov 29, 2024
PURPOSE: Synthetic computed tomography (sCT)-algorithms, which generate computed tomography images from magnetic resonance imaging data, are becoming part of the clinical radiotherapy workflow. The aim of this retrospective study was to evaluate and ...
BACKGROUND: Bi-parametric magnetic resonance imaging (bpMRI) has demonstrated promising results in prostate cancer (PCa) detection. Vision transformers have achieved competitive performance compared to convolutional neural network (CNN) in deep learn...
BACKGROUND: For biochemical recurrence following radical prostatectomy for prostate cancer, treatments such as radiation therapy and androgen deprivation therapy are administered. To diagnose postoperative recurrence as early as possible and to inter...
This bicenter retrospective analysis included 162 patients who had undergone prostate biopsy following prebiopsy MRI, excluding those with PCa identified only in the peripheral zone (PZ). DLR T2WI achieved a 69% reduction in scan time relative to TSE...
Prostate-specific antigen (PSA) is the most commonly used marker of prostate cancer. However, nearly 25% of men with elevated PSA levels do not have cancer and nearly 20% of patients with prostate cancer have normal serum PSA levels. Therefore, in th...
Computer methods and programs in biomedicine
Nov 20, 2024
INTRODUCTION: Prostate cancer remains a significant health concern, with radical prostatectomy being a common treatment approach. However, predicting postoperative functional outcomes, particularly urinary continence and erectile function, poses chal...